Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nelotanserin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 839713-36-9, Apd125, Apd-125, 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea, 1-[3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea, 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
    Molecular Formula
    C18H15BrF2N4O2
    Molecular Weight
    437.2  g/mol
    InChI Key
    COSPVUFTLGQDQL-UHFFFAOYSA-N
    FDA UNII
    4ZA73QEW2P
    Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM or dream sleep. Nelotanserin works through a mechanism of action that is different from currently marketed drugs.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
    2.1.2 InChI
    InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)
    2.1.3 InChI Key
    COSPVUFTLGQDQL-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC
    2.2 Other Identifiers
    2.2.1 UNII
    4ZA73QEW2P
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 839713-36-9

    2. Apd125

    3. Apd-125

    4. 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea

    5. 1-[3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea

    6. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea

    7. 4za73qew2p

    8. Chembl598172

    9. 1-(3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl)-3-(2,4-difluorophenyl)urea

    10. N-[3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl]-n'-(2,4-difluorophenyl)-urea

    11. Nelotanserin [usan:inn]

    12. Unii-4za73qew2p

    13. Apd125(nelotanserin)

    14. Nelotanserin (usan/inn)

    15. Nelotanserin [inn]

    16. Nelotanserin [usan]

    17. Schembl2345325

    18. Apd 125

    19. Dtxsid40232868

    20. Chebi:177438

    21. Bcp24992

    22. Ex-a3147

    23. Bdbm50324541

    24. Mfcd16619341

    25. Zinc38239930

    26. Cs-5984

    27. Db12555

    28. Sb19023

    29. As-30117

    30. Hy-10559

    31. D09645

    32. 713b369

    33. Q6990276

    34. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea

    35. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea

    36. 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-diluorophenyl)urea

    37. 1-(3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl)-3-(2,4- Difluorophenyl)urea

    38. Urea, N-(3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl)-n'-(2,4-difluorophenyl)-

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 437.2 g/mol
    Molecular Formula C18H15BrF2N4O2
    XLogP33.3
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count4
    Exact Mass436.03464 g/mol
    Monoisotopic Mass436.03464 g/mol
    Topological Polar Surface Area68.2 Ų
    Heavy Atom Count27
    Formal Charge0
    Complexity518
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 Mechanism of Action

    Nelotanserin potently and selectively targets the 5-HT2A serotonin receptor, blocking a stimulatory pathway of the central nervous system. This mechanism is not expected to have the side effects of the GABA-A treatments.

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.